KDEV.ST

Karolinska Development AB (publ) [KDEV.ST] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

KDEV.ST Stock Summary

Top 10 Correlated ETFs

KDEV.ST

Top 10 Correlated Stocks

KDEV.ST

In the News

KDEV.ST Financial details

Company Rating
-
Market Cap
415.35M
Income
-37.81M
Revenue
1.85M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
8
Optionable
No
Shortable
Yes
Earnings
26 Apr 2024
P/E
7.78
Forward P/E
-
PEG
-1.03
P/S
235.23
P/B
0.39
P/C
-
P/FCF
-18.61
Quick Ratio
16.63
Current Ratio
17.06
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.14
EPS next Y
-
EPS next Q
-
EPS this Y
-103.57%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-69.74%
Revenue last 5Y
-3.67%
Revenue Q/Q
-9.47%
EPS Q/Q
-115.51%
-
-
-
-
SMA20
-7.07%
SMA50
-12.38%
SMA100
-14.02%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
5%
ROC
0.04%
Gross Margin
100%
Oper. Margin
2679%
Profit Margin
3051%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.41-1.948
52W High
-9.9%
52W Low
-9.9%
RSI
45.39
Rel Volume
1.91
Avg Volume
141.17K
Volume
269.24K
Perf Week
-4.05%
Perf Month
-14.19%
Perf Quarter
-25.54%
Perf Half Y
-26.15%
-
-
-
-
Beta
0.383
-
-
Volatility
0.02%, 0.06%
Prev Close
-4.15%
Price
0.901
Change
-3.43%

Something similar

Top by Market Cap
1YD.DE
AMZ.DE
AVGO
VFINX
BRK-A
Top Correlated ETFs
OIGS.DE
AMEE.DE
LOGS.DE
CN1G.DE
ESIN.DE
Top Correlated Stocks
INVE-A.ST
BNP.PA
PHIA.AS
RXL.PA
VK.PA
Similar Market Cap
0IKK.L
IDTW.L
SFEPX
IPF.L
AFTR

Company Profile

Healthcare Biotechnology

Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. Karolinska Development AB (publ) was founded in 2003 and is headquartered in Stockholm, Sweden.